109 related articles for article (PubMed ID: 28368904)
1. Preparation and anticancer activity evaluation of an amorphous drug nanocomposite by simple heat treatment.
Zhan H; Liang JF
Anticancer Drugs; 2017 Jul; 28(6):623-633. PubMed ID: 28368904
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anticancer activity of drug nanoparticles formulated with β-cyclodextrin.
Zhan H; Jagtiani T; Liang JF
Anticancer Drugs; 2017 Mar; 28(3):271-280. PubMed ID: 27926611
[TBL] [Abstract][Full Text] [Related]
3. A new targeted delivery approach by functionalizing drug nanocrystals through polydopamine coating.
Zhan H; Jagtiani T; Liang JF
Eur J Pharm Biopharm; 2017 May; 114():221-229. PubMed ID: 28161549
[TBL] [Abstract][Full Text] [Related]
4. Lytic peptide-grafted beta-cyclodextrin polymer based nano-scaled drug delivery system with enhanced camptothecin anti-cancer efficacy.
Zhan H; Zhao H; Muhammad N; Li T; Liu Y; Wang J
Nanotechnology; 2020 Feb; 31(7):075101. PubMed ID: 31665708
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes.
Chen M; Li W; Zhang X; Dong Y; Hua Y; Zhang H; Gao J; Zhao L; Li Y; Zheng A
Int J Nanomedicine; 2017; 12():5487-5500. PubMed ID: 28814865
[TBL] [Abstract][Full Text] [Related]
6. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
8. Loading studies of the anticancer drug camptothecin into dual stimuli-sensitive nanoparticles. Stability scrutiny.
Iglesias N; Galbis E; Díaz-Blanco MJ; de-Paz MV; Galbis JA
Int J Pharm; 2018 Oct; 550(1-2):429-438. PubMed ID: 30196142
[TBL] [Abstract][Full Text] [Related]
9. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
10. Amphiphilic star PEG-Camptothecin conjugates for intracellular targeting.
Omar R; Bardoogo YL; Corem-Salkmon E; Mizrahi B
J Control Release; 2017 Jul; 257():76-83. PubMed ID: 27677603
[TBL] [Abstract][Full Text] [Related]
11. Lipid-complexed camptothecin: formulation and initial biodistribution and antitumor activity studies.
Sugarman SM; Zou Y; Wasan K; Poirot K; Kumi R; Reddy S; Perez-Soler R
Cancer Chemother Pharmacol; 1996; 37(6):531-8. PubMed ID: 8612306
[TBL] [Abstract][Full Text] [Related]
12. Preparation, formula optimization and antitumor actions of mannitol coupling camptothecin nanoparticles.
Wang Z; Li Q; Zhao X; Sun B; Zhu Q; Gao W; Hua C
Int J Pharm; 2014 Apr; 465(1-2):360-7. PubMed ID: 24530520
[TBL] [Abstract][Full Text] [Related]
13. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
14. Rational Design of a New Self-Codelivery System from Redox-Sensitive Camptothecin-Cytarabine Conjugate Assembly for Effectively Synergistic Anticancer Therapy.
He W; Hu X; Jiang W; Liu R; Zhang D; Zhang J; Li Z; Luan Y
Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29076266
[TBL] [Abstract][Full Text] [Related]
15. Nanocarrier improves the bioavailability, stability and antitumor activity of camptothecin.
Tang XJ; Han M; Yang B; Shen YQ; He ZG; Xu DH; Gao JQ
Int J Pharm; 2014 Dec; 477(1-2):536-45. PubMed ID: 25445532
[TBL] [Abstract][Full Text] [Related]
16. Extreme Activity of Drug Nanocrystals Coated with A Layer of Non-Covalent Polymers from Self-Assembled Boric Acid.
Zhan H; Liang JF
Sci Rep; 2016 Dec; 6():38668. PubMed ID: 27934922
[TBL] [Abstract][Full Text] [Related]
17. Dysoxylum binectariferum bark as a new source of anticancer drug camptothecin: bioactivity-guided isolation and LCMS-based quantification.
Jain SK; Meena S; Gupta AP; Kushwaha M; Uma Shaanker R; Jaglan S; Bharate SB; Vishwakarma RA
Bioorg Med Chem Lett; 2014 Jul; 24(14):3146-9. PubMed ID: 24878199
[TBL] [Abstract][Full Text] [Related]
18. Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.
Svenson S; Wolfgang M; Hwang J; Ryan J; Eliasof S
J Control Release; 2011 Jul; 153(1):49-55. PubMed ID: 21406204
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and optimization of a bifunctional hyaluronan-based camptothecin prodrug.
Xu Z; Zheng W; Yin Z
Arch Pharm (Weinheim); 2014 Apr; 347(4):240-6. PubMed ID: 24402828
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.
Chao P; Deshmukh M; Kutscher HL; Gao D; Rajan SS; Hu P; Laskin DL; Stein S; Sinko PJ
Anticancer Drugs; 2010 Jan; 21(1):65-76. PubMed ID: 19966540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
